The J.P. Morgan Healthcare Conference has commenced in San Francisco, attracting significant attention from healthcare executives and investors. Noteworthy participants include major companies like GSK and Bayer, who are poised to share their latest developments and strategies. With a heightened focus on mergers and acquisitions (M&A), experts predict a revival in mega healthcare deals, despite a backdrop of policy uncertainties. Security measures have been intensified following recent events, ensuring safety for all attendees. The conference aims to navigate the investor landscape, spotlighting key trends such as obesity treatments and transformative legal developments in the biopharma sector. As leading CEOs converge for the event, hopes are high for a boost in market sentiment and potential deal-making.